Literature DB >> 22450898

Update in liver transplantation.

Saleh A Alqahtani1.   

Abstract

PURPOSE OF REVIEW: Successful transplant outcomes require optimal patient selection and timing. This review will update clinicians with current status and challenges in liver transplantation. Currently, the major limitation facing liver transplant centers is the shortage of organs. The limited availability of organs has led to long waiting periods for liver transplantation and consequently many patients become seriously ill or die while on the waiting list. RECENT
FINDINGS: This has major implications in the selection of patients, as well as the timing of transplant, for optimal use of these scarce organs. Indications and contraindications have changed slightly over the years and will be reviewed in this article.
SUMMARY: Timing for transplantation has changed more dramatically in the recent years because major changes to organ allocation systems have been undertaken to provide clinicians with a better way to prioritize patients for liver transplant.

Entities:  

Mesh:

Year:  2012        PMID: 22450898     DOI: 10.1097/MOG.0b013e3283527f16

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  12 in total

Review 1.  Liver-Regenerative Transplantation: Regrow and Reset.

Authors:  A Collin de l'Hortet; K Takeishi; J Guzman-Lepe; K Handa; K Matsubara; K Fukumitsu; K Dorko; S C Presnell; H Yagi; A Soto-Gutierrez
Journal:  Am J Transplant       Date:  2016-02-18       Impact factor: 8.086

2.  Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure.

Authors:  Marek Saracyn; Marek Brytan; Robert Zdanowski; Tomasz Ząbkowski; Przemysław Dyrla; Janusz Patera; Stanisław Wojtuń; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

3.  8-pCPT-cGMP prevents mitochondrial depolarization and improves the outcome of steatotic partial liver transplantation.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

Review 4.  Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.

Authors:  Arno Kornberg
Journal:  World J Hepatol       Date:  2015-06-18

5.  Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients.

Authors:  Sami Akbulut; Cuneyt Kayaalp; Mehmet Yilmaz; Volkan Ince; Dincer Ozgor; Koray Karabulut; Cengiz Eris; Huseyin Ilksen Toprak; Cemalettin Aydin; Sezai Yilmaz
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 6.  Liver transplantation: past, present and future.

Authors:  Ali Zarrinpar; Ronald W Busuttil
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-11       Impact factor: 46.802

7.  Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts.

Authors:  Dany Habka; David Mann; Ronald Landes; Alejandro Soto-Gutierrez
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  Murine Sca1(+)Lin(-) bone marrow contains an endodermal precursor population that differentiates into hepatocytes.

Authors:  Keunhee Oh; Suh Youn Shon; Myung Won Seo; Hak Mo Lee; Ju-Eun Oh; Eun Young Choi; Dong-Sup Lee; Kyong Soo Park
Journal:  Exp Mol Med       Date:  2015-10-02       Impact factor: 8.718

9.  Disrupted Renal Mitochondrial Homeostasis after Liver Transplantation in Rats.

Authors:  Qinlong Liu; Yasodha Krishnasamy; Hasibur Rehman; John J Lemasters; Rick G Schnellmann; Zhi Zhong
Journal:  PLoS One       Date:  2015-10-19       Impact factor: 3.240

10.  Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.

Authors:  Qinlong Liu; Hasibur Rehman; Yanjun Shi; Yasodha Krishnasamy; John J Lemasters; Charles D Smith; Zhi Zhong
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.